ArticleVaccines2023

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.

Freek Cox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.